Results 161 to 170 of about 38,448 (217)

<i>Streptococcus pneumoniae</i> serotypes and factors associated with antimicrobial resistance in Invasive pneumococcal disease cases in Latvia, 2012-2022. [PDF]

Front Public Health
Savrasova L, Villerusa A, Zeltina I, Krumina A, Cupeca H, Balasegaram S, Greve M, Savicka O, Selderina S, Galajeva J, Dushacka D.   +10 more
europepmc   +1 more source

Invasive pneumococcal disease in Argentina: a snapshot from a retrospective observational study on serotypes, antimicrobial resistance, and the potential impact of the COVID-19 pandemic (2018-2022). [PDF]

Lancet Reg Health Am
Zintgraff J, Gagetti P, Eluchans NS, Marchetti P, Moscoloni MA, Irazu L, Lara CS, Argentina Spn Working Group, Corso A.   +8 more
europepmc   +1 more source

Immunogenicity of DTaP-IPV-Hib and MenC vaccines in the UK when administered with a 13-valent pneumococcal conjugate vaccine

, 2008
Baker, S., Daniels, E., Dymond, S., Faust, S.N., Finn, A., Galiza, E., Gruber, W., Heath, P.T., John, T., Klinger, C., Layton, H., Pestridge, S., Pollard, A., Scott, D., Snape, M., Tansey, S.   +15 more
core  

Long-term survival after invasive pneumococcal disease – a matched cohort study using electronic health records in England

Suffel A, Abdullahi F, Barry E, Walker J, Andrews N, Amin-Chowdhury Z, Ladhani SN, Grint D, McDonald HI, Douglas I, Mansfield KE, Parker EP.   +11 more
europepmc   +1 more source